OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

CFO exercised or converted 40K CORT derivative securities | OQRO

Home
Insider trades
Corcept Therapeutics
CFO exercised or converted 40K CORT derivative securities

Insider trades

Insider trade

CFO exercised or converted 40K CORT derivative securities

Traded Jun 1, 2026 · Filed Jun 4, 2026

CORCorcept TherapeuticsCORT

40K
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 1, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 4, 2026

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001193125-26-256011
Filed / recorded

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Jun 4, 2026, 3:20 AM UTC

Added to OQRO

Oct 6, 2026, 7:14 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

CORCEPT THERAPEUTICS INC

Issuer CIK

1088856

Ticker

CORT

Reporting person

Atabak Mokari

Relationship

Officer

Officer title

Chief Financial Officer

Security

Stock option (right to buy)

Table

Derivative (Table II)

Transaction date

Jun 1, 2026

Transaction code

Shares / units

40,000

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

60,000

Ownership form

Direct

Amendment

Footnotes from the filing

Fully exercisable.

Around the same time

Director sold ~$345K of Corcept Therapeutics

Scheduled in advance4mo ago

Director sold ~$487K of Corcept Therapeutics

Scheduled in advance4mo ago

Director sold

~$1.69MReported value · 20K sh @ $84.53

4mo ago

A board member of Corcept Therapeutics sold $1.69M of Corcept Therapeutics shares. Nobody planned it ahead of time.

More Official record